National Cancer Institute - Alliance for Nanotechnology in Cancer
U.S. National Institutes of Health | nano.cancer.gov
 
 
National Cancer Institute NCI Alliance for Nanotechnology in Cancer
Nanotechnology:
Critical Endeavor
in Cancer

>  Why Nanotechnology?
>  Nanowires
>  Cantilevers
>  Nanoshells
>  Nanoparticles

Nanotechnology
Centers of Excellence
>  Mission
Multidisciplinary
Research Teams
>  Mission
Nanotechnology
Platforms for Cancer
Research
>  Mission
Nanotechnology
Characterization
Lab (NCL)
>  Mission

Nanotech Highlights

NCI Alliance for Nanotechnology in Cancer
PRE-APPLICATION MEETING
December 14, 2004

National Institutes of Health
Natcher Conference Center
Bethesda, Maryland
[more info]

NCAB Meeting
Tuesday, September 14, 2004
Mini-Symposium:
The Science of Nanotechnology
10:45am - 12:30pm
[Program Agenda]
[Speaker Bios]

Alliance Launch Day
Monday, September 13, 2004
Natcher Conference Center
NIH Bethesda, Maryland


Going Small For
Big Advances

Cancer Nanotechnology Brochure


Download This Brochure To
Learn More


Director's Statement

Message From The Director

Nanotechnology: Critical Endeavor in Cancer
Why Nanotechnology in Cancer - Nanowires - Cantilevers - Nanoshells - Nanoparticles

Nanotechnology: Critical Endeavor in Cancer


Reference: Jennifer West, Rice University


Replay Animation


Previous Animation | Next Animation

Nanoshells

Nanoshells have a core of silica and a metallic outer layer. These nanoshells can be injected safely, as demonstrated in animal models.

Because of their size, nanoshells will preferentially concentrate in cancer lesion sites. This physical selectivity occurs through a phenomenon called enhanced permeation retention (EPR).

Scientists can further decorate the nanoshells to carry molecular conjugates to the antigens that are expressed on the cancer cells themselves or in the tumor microenvironment. This second degree of specificity preferentially links the nanoshells to the tumor and not to neighboring healthy cells.

As shown in this example, scientists can then externally supply energy to these cells. The specific properties associated with nanoshells allow for the absorption of this directed energy, creating an intense heat that selectively kills the tumor cells. The external energy can be mechanical, radio frequency, optical – the therapeutic action is the same.

The result is greater efficacy of the therapeutic treatment and a significantly reduced set of side effects.

Reference Scientific Bibliography:
   Nanotechnology - Enabled Therapeutics Development and Delivery

 

   



A Service of the National Cancer Institute
Department of Health and Human ServicesNational Institutes of HealthFirstGov.gov